Further studies have shown that WTAP promotes metastasis and chemoresistance to gemcitabine via stabilizing Fak mRNA, and a specific FAK inhibitor, GSK2256098, could restore WTAP-mediated chemoresistance and metastasis in pancreatic cancer 68. This evidence concerns the gene PTK2 and pancreatic neoplasm.